Andy Pasternak, EVP, Chief Strategy Officer: Horizon Therapeutics Public HZNP Sell · Filed 23/01/18

Trade details

Type: Insider sale
Amount: $3,066,390.87
Shares · price: 27,129 sh · $113.03 a share
Held after: 56,338 sh
Stock: Horizon Therapeutics Public HZNP
Person: Andy PasternakEVP, Chief Strategy Officer
Trade date: 23/01/17
Filed: 23/01/18
Days to filing: 1 days

Sold 32.5% of holdings

Share of holding sold: 32.5%

Horizon Therapeutics Public trades, last 26 weeks

What else happened in Horizon Therapeutics Public around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Andy Pasternak's recent trades

No other trades yet.